Seeking Alpha

Jeremy's friend's  Instablog

Jeremy's friend
Send Message
Looking for good articles.
  • FDA Asks GSK To Change Labeling For Lovaza To Add Atrial Fibrillation On Sept.4th,2012 0 comments
    Sep 7, 2012 3:04 PM | about stocks: AMRN, GSK, PFE, MRK, AZN

    FDA has asked Glaxo to change labeling for Lovaza to show Atrial Fibrillation .This is when heart rhythm is irregular.

    This letter and pdf was published on Sept.4th,2012.

    This risk helps doctors prescribe Vascepa which is better for Cardiac known factors like LDL--Lovaza raises LDL,where Vascepa does not(actually lowers it.)

    Disclosure: I am long AMRN.

    Stocks: AMRN, GSK, PFE, MRK, AZN
Back To Jeremy's friend's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

Latest Comments


Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.